| 1 |
Landolfi R, Marchioli R, Kutti J, et al. Efficacy and safety of low-dose aspirin in polycythemia vera. N Engl J Med 2004;350:114-124.
DOI
ScienceOn
|
| 2 |
Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008;22:14-22.
DOI
ScienceOn
|
| 3 |
Bang SM, Kim HY, Kim HJ, et al. Diagnostic and therapeutic guideline for myeloproliferative neoplasm. J Korean Med Assoc 2011;54:112-126.
DOI
ScienceOn
|
| 4 |
Barbui T, Finazzi MC, Finazzi G. Front-line therapy in polycythemia vera and essential thrombocythemia. Blood Rev 2012;26:205-211.
DOI
ScienceOn
|
| 5 |
Squizzato A, Romualdi E, Passamonti F, Middeldorp S. Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia. Cochrane Database Syst Rev 2013;4:CD006503.
|
webmaster
